Cargando…
Botulinum Toxin Treatment of Adult Muscle Stem Cells from Children with Cerebral Palsy and hiPSC-Derived Neuromuscular Junctions
Botulinum neurotoxin type-A (BoNT) injections are commonly used as spasticity treatment in cerebral palsy (CP). Despite improved clinical outcomes, concerns regarding harmful effects on muscle morphology have been raised, and the BoNT effect on muscle stem cells remains not well defined. This study...
Autores principales: | Costamagna, Domiziana, Bastianini, Valeria, Corvelyn, Marlies, Duelen, Robin, Deschrevel, Jorieke, De Beukelaer, Nathalie, De Houwer, Hannah, Sampaolesi, Maurilio, Gayan-Ramirez, Ghislaine, Campenhout, Anja Van, Desloovere, Kaat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453788/ https://www.ncbi.nlm.nih.gov/pubmed/37626881 http://dx.doi.org/10.3390/cells12162072 |
Ejemplares similares
-
Muscle Microbiopsy to Delineate Stem Cell Involvement in Young Patients: A Novel Approach for Children With Cerebral Palsy
por: Corvelyn, Marlies, et al.
Publicado: (2020) -
Reduced Cross-Sectional Muscle Growth Six Months after Botulinum Toxin Type-A Injection in Children with Spastic Cerebral Palsy
por: De Beukelaer, Nathalie, et al.
Publicado: (2022) -
Fine-needle percutaneous muscle microbiopsy technique as a feasible tool to address histological analysis in young children with cerebral palsy and age-matched typically developing children
por: Deschrevel, Jorieke, et al.
Publicado: (2023) -
Autologous iPSC-Derived Human Neuromuscular Junction to Model the Pathophysiology of Hereditary Spastic Paraplegia
por: Costamagna, Domiziana, et al.
Publicado: (2022) -
Human iPSC model reveals a central role for NOX4 and oxidative stress in Duchenne cardiomyopathy
por: Duelen, Robin, et al.
Publicado: (2022)